Form 4: Labcorp EVP, CHRO Anita Z. Graham Reports Stock Option Grant and Restricted Stock Unit Award

Anita Z. Graham, EVP, CHRO of Labcorp Holdings Inc., reports the acquisition of stock options and restricted stock units.

Summary

• On February 11, 2025, Anita Z. Graham, EVP, CHRO of Labcorp Holdings Inc., was granted non-qualified stock options to purchase 3,200 shares of common stock at an exercise price of $245.14.
• These options vest in three equal annual installments beginning February 11, 2026, and expire on February 10, 2035.
• Graham also received 1,070 restricted stock units (RSUs), each representing the right to receive one share of Labcorp Holdings Inc. common stock.
• These RSUs vest in three equal annual installments beginning on February 11, 2026.
• Following these transactions, Graham directly owns 3,200 non-qualified stock options and 2,091 restricted stock units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices, aligning management with shareholder interests. There are no immediate negative implications.

Positives

• The grant of stock options and RSUs aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The vesting schedules for the stock options and RSUs suggest a continued commitment from the executive to the company's long-term performance.

Industry Context

Stock option and RSU grants are common forms of executive compensation in publicly traded companies, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Executive compensation packages, including stock options and RSUs, are common practice among publicly traded companies like Labcorp.
• Companies such as Quest Diagnostics and Bio-Reference Laboratories also utilize similar equity-based compensation to incentivize their executives.
• The vesting schedules and grant sizes are generally benchmarked against industry peers to ensure competitiveness and retention.

Stakeholder Impact

• Shareholders may view the equity grants as a positive sign, aligning executive interests with long-term company performance.
• Employees may see the grants as a reflection of the company's commitment to its leadership team.

Key Dates

Keywords

stock options, restricted stock units, Form 4, insider trading, executive compensation, Labcorp Holdings Inc., Anita Z. Graham, CHRO, equity